As researchers dive deeper into the applications of lab-grown cells, the vision of personalized, regenerative medicine moves closer to reality.... Nov 07
Early identification of at-risk individuals could facilitate targeted preventive measures, such as prioritizing these individuals for vaccines or antiviral treatments to reduce the severity ... Jul 22
Researchers call for regulatory action after highlighting security and privacy concerns in female-oriented technologies (FemTech).... Mar 13
Mental health disorders are faced by a wide range of populations across India. But people continue to suffer due to stigma and a lack of ... Jul 15
With only 10,000 radiologists for 1.3 billion Indians, it is important to bridge this gap to ensure millions of Indians get access to ... Mar 25
Globally, around 3.3 million people suffer from upper limb amputee of which only a mere 2-3% have access to rehabilitative devices or technologies. ... Jan 22
Swiss healthcare giant Novartis has agreed to pay $1.5 billion to acquire British biotech company Gyroscope Therapeutics. ... Dec 24
In its Series C round, Varun Khanna’s Fullife Healthcare raised $22 million from Morgan Stanley Private Equity Asia or MSPEA. Read to find out ... Dec 15
In the period between 1988-89, the company only manufactured penicillin. They have since then expanded into antibiotics, anti-allergic, antiretrovirals, cardiovascular, central nervous system ... Sep 21
We need to create safe spaces for ourselves and people around us where we can express what we want out of life and be content ... Mar 15
This worldwide exclusive license to Merck KGaA, Darmstadt, Germany for the development and commercialization of Xevinapant ... Mar 03
... Feb 23
Lonza’s shares rose more than 60% last year, as it expanded in drugs and prepared to unload Specialty Ingredients. ... Feb 09
Brand Institute, the global leader in pharmaceutical and healthcare-related name development, is proud to announce its role in naming Pfizer and BioNTech's COVID-... Dec 29
... Dec 23
The licensing agreement will be effective in 33 countries throughout the European region including France, Italy, and Spain... Dec 23
Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk of disease recurrence or death by 80%... Dec 21
Today, the U.S. Food and Drug Administration approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose ... Dec 19
ObsEva, today announced topline 52-week PRIMROSE 1 and 76-week PRIMROSE 2 results of Yselty, in development for the treatment of women with heavy ... Dec 10
Virocule Inc. today announced that it has received authorization from Health Canada for the sale of its ANOSMICTM COVID-19 Smell Tester. ... Dec 10
Novartis and Molecular Partners AG today announced a collaboration to develop two DARPin® therapies designed for potential use against COVID-19... Oct 28
Basilea announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ramucirumab in the ongoing FIDES-03 study with derazantinib in gastric ... Oct 28
Anti-tumor immune memory and iADC platform are showing results ... Oct 27
PALFORZIA recieves CHMP for Europe... Oct 19
... Oct 17
-Advertisements-
.jpeg)
Friday, November 22, 2024
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)